October 2020 - Page 23 of 26

MondayOct 05, 2020 2:00 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. Announces New Board Appointments

KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a clinical-stage biotechnology company, recently announced the appointment of Professor Richard Barker, Larry Gold Md., Shoshana Shendelman PhD., and Donald McGovern Jr. to its board of directors, upon completion of the business combination. 180 Life Sciences is led by Dr. James Woody, who previously served as the founding CEO of OncoMed Pharmaceuticals and president and general manager of Roche Bioscience. “I’m pleased to welcome Richard, Larry,…

MondayOct 05, 2020 1:44 pm

InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF) Partners with Hub International to Expand Hospitality Liability Coverage

The partnership will help InsuraGuest’s coverage potentially reach more than 9,300 hospitality customers in the United States and Canada by the middle of 2021 Hospitality Liability coverage allows covered properties to transfer certain liabilities, lowering claim ratio and risk profiles InsuraGuest’s product can also help properties generate revenue by keeping a percent of the nightly software fee Innovative insurtech leader InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF) has sealed a premier preferred partnership with leading global insurance brokerage Hub International Limited (“HUB”), to provide InsuraGuest’s Hospitality Liability coverage to properties in Hub International’s portfolio. Signed via wholly owned subsidiary InsuraGuest, the…

MondayOct 05, 2020 12:51 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials

Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or in Q1 of 2021, building on promising results shown in initial trials One patient in the Phase I trial has remained cancer-free over the course of 14 years, and 44 percent of the patients who could be evaluated experienced a clinically significant positive response to Berubicin CNS’s laser-focused strategy for developing a GBM therapy is also leading the company to…

MondayOct 05, 2020 12:27 pm

Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment products The company’s core mission has been to help small, community-centered retail pharmacies compete with large national chains through prescription drug price transparency and AI-driven protocols that help pharmacies stay abreast of what’s available Trxade Group’s advances in delivering services ranging from consultation to drug…

MondayOct 05, 2020 11:46 am

QualityStocksNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Issues Corporate Update

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today provided a general corporate update. Among highlights provided in the update, LexaGene is in a strong position to support its development goals for the next year and beyond with its treasury currently standing at US$11.3 million (C$14.9 million). “Our MiQLab(TM) pathogen detection system has 230 unique components. Over the summer, the coronavirus pandemic caused some supply chain issues for several key components that delayed the manufacturing, optimization and testing of these systems. Just recently, these supply chain issues were resolved and…

MondayOct 05, 2020 11:33 am

Sugarmade (SGMD) 8K Filing Notes Status, Potential of Upcoming LA-Based Cannabis-Delivery Locations

SGMD has filed updated Form 8K Current Report with SEC Filing includes information about issues related to company’s status, including planned expansion of BudCars cannabis-delivery service Sugarmade sees “major business opportunities out of both sites once operations begin” Sugarmade (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, has released the publication of a Form 8K Current Report filing with the United States Securities and Exchange Commission (“SEC”) (https://ibn.fm/Ngrsg). The filing includes specific information about several issues related to the company’s performance and outlook, including planned expansion of the BudCars cannabis delivery service.…

MondayOct 05, 2020 10:56 am

Rritual Mushrooms Inc. is “One to Watch”

Rritual’s suite of premium functional mushroom and adaptogenic elixirs is designed to offer various health benefits, such as increased immunity, cognitive function, stress management and more The company’s products are expected to be available online through Rritual’s site and Amazon by fall 2020 The Rritual team has extensive ties and influential relationships with leading retail businesses, providing a wide market for growth The functional mushroom industry has no clear and dominant leader, allowing Rritual to target this role with its premium products. Rritual is currently the only premium brand on the market The global functional mushroom market is expected to…

MondayOct 05, 2020 10:54 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Elects Leading International Expert as Board Chairman

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), today announced the election of Dr. Roger McIntyre as chairman of its board of directors. A foremost international expert in depression and suicide, Dr. McIntyre is a professor of Psychiatry and Pharmacology at the University of Toronto, heads the Mood Disorders Unit at the University Health Network in Toronto and holds appointments among scientific and clinical organizations across the United States and Asia. Dr. McIntyre was appointed to Champignon’s board in July 2020 and assumed the role of CEO in May 2020. He has set a strategic direction for the business, which…

MondayOct 05, 2020 10:21 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Appoints Digital Media Exec as BIGtoken CEO

SRAX (NASDAQ: SRAX), a financial technology solutions provider, today announced that one of its board members, Malcolm CasSelle, will be appointed chief executive officer of BIGtoken, a wholly owned subsidiary of SRAX. In addition to his seven-year tenure on SRAX’s board of directors, CasSelle brings a close relationship with BIGtoken and more than 20 years of C-suite experience leading several startups in the digital media industry. “Malcolm brings years of experience in building technology companies,” SRAX CEO Christopher Miglino said in the news release. “He has the relationships and the know-how to bring the company to the next level and…

MondayOct 05, 2020 9:52 am

QualityStocksNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Issues Update on Non-Compliance with Nasdaq Listing Requirements

Youngevity International (NASDAQ: YGYI), a leading multichannel lifestyle company operating in three distinct business segments, on Friday announced its receipt of a September 29, 2020, Staff Determination Letter (the "September Notification") from the Listing Qualifications Department of the Nasdaq Stock Market LLC. According to the update, the letter indicated that Youngevity did not meet the terms of the exception previously granted to it by Nasdaq (the "Exception") pursuant to the notification letter received by the company on August 11, 2020. Under the Exception, in order to regain compliance with Nasdaq Listing Rule 5250(c)(1), the company was obligated to have filed…

Site Search

Company Search

Month: October 2020